These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 23791402)
41. A clinical study on plasma biomarkers for deciding the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia of premature infants. Zhu H; Tian Y; Cheng H; Zheng Y; Wang W; Bao T; Wu R; Tian Z Int J Med Sci; 2021; 18(12):2581-2588. PubMed ID: 34104089 [No Abstract] [Full Text] [Related]
42. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. Vom Hove M; Prenzel F; Uhlig HH; Robel-Tillig E J Pediatr; 2014 Jan; 164(1):40-45.e4. PubMed ID: 24055328 [TBL] [Abstract][Full Text] [Related]
43. The level of extracellular superoxide dismutase in the first week of life in very and extremely low birth weight infants and the risk of developing bronchopulmonary dysplasia. Kicinski P; Malachowska B; Wyka K; Gach A; Jakubowski L; Gulczynska E J Perinat Med; 2019 Aug; 47(6):671-676. PubMed ID: 31365347 [TBL] [Abstract][Full Text] [Related]
44. Elevated levels of fetal hemoglobin synthesis in infants with bronchopulmonary dysplasia. Bard H; Prosmanne J Pediatrics; 1990 Aug; 86(2):193-6. PubMed ID: 1695343 [TBL] [Abstract][Full Text] [Related]
45. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
46. Increased serum Th2 chemokine levels are associated with bronchopulmonary dysplasia in premature infants. Zhou D; Shi F; Xiong Y; Zhou M; Wan H; Liu H Eur J Pediatr; 2019 Jan; 178(1):81-87. PubMed ID: 30324231 [TBL] [Abstract][Full Text] [Related]
47. Transthyretin levels are not related to Apgar score in low birth weight and very low birth weight infants. Su PH; Wang SL; Chen JY; Hu JM; Chang HP; Chen SJ Early Hum Dev; 2008 Aug; 84(8):533-8. PubMed ID: 18252270 [TBL] [Abstract][Full Text] [Related]
48. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD. Fukunaga S; Ichiyama T; Maeba S; Okuda M; Nakata M; Sugino N; Furukawa S Pediatr Pulmonol; 2009 Mar; 44(3):267-72. PubMed ID: 19205055 [TBL] [Abstract][Full Text] [Related]
49. MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Schulz CG; Sawicki G; Lemke RP; Roeten BM; Schulz R; Cheung PY Pediatr Res; 2004 May; 55(5):794-801. PubMed ID: 14973177 [TBL] [Abstract][Full Text] [Related]
50. Erythrocyte Cu/Zn superoxide dismutase activity in preterm infants with and without bronchopulmonary dysplasia. Fu RH; Yang PH; Chiang MC; Chiang CC; Cho YH; Chou YH Biol Neonate; 2005; 88(1):35-41. PubMed ID: 15767740 [TBL] [Abstract][Full Text] [Related]
51. Serial changes of serum endostatin and angiopoietin-1 levels in preterm infants with severe bronchopulmonary dysplasia and subsequent pulmonary artery hypertension. Kim DH; Kim HS Neonatology; 2014; 106(1):55-61. PubMed ID: 24818792 [TBL] [Abstract][Full Text] [Related]
52. Bronchopulmonary dysplasia in very low birth weight infants is associated with prolonged hospital stay. Klinger G; Sirota L; Lusky A; Reichman B J Perinatol; 2006 Oct; 26(10):640-4. PubMed ID: 17006525 [TBL] [Abstract][Full Text] [Related]
53. Reduced mortality and increased BPD with histological chorioamnionitis and leukocytosis in very-low-birth-weight infants. Paul DA; Zook K; Mackley A; Locke RG J Perinatol; 2010 Jan; 30(1):58-62. PubMed ID: 19710675 [TBL] [Abstract][Full Text] [Related]
54. Association of cord blood Ang-1 and sCD105 levels with bronchopulmonary dysplasia in preterm infants. Yang J; Wang Y; Wu Y; Fan H; Jin O; Tang L; Tung TH; Zhang M; Wang L BMC Pediatr; 2024 Jul; 24(1):451. PubMed ID: 39010003 [TBL] [Abstract][Full Text] [Related]
55. Vitamin E and selenium levels of premature infants with severe respiratory distress syndrome and bronchopulmonary dysplasia. Falciglia HS; Ginn-Pease ME; Falciglia GA; Lubin AH; Frank DJ; Chang W J Pediatr Perinat Nutr; 1988; 2(1):35-49. PubMed ID: 3216334 [No Abstract] [Full Text] [Related]
56. Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1. Ramsay PL; O'Brian Smith E; Hegemier S; Welty SE Pediatrics; 1998 Oct; 102(4 Pt 1):927-32. PubMed ID: 9755267 [TBL] [Abstract][Full Text] [Related]
57. Survival rate and prevalence of bronchopulmonary dysplasia in extremely low birth weight infants. Latini G; De Felice C; Giannuzzi R; Del Vecchio A Early Hum Dev; 2013 Jun; 89 Suppl 1():S69-73. PubMed ID: 23809356 [TBL] [Abstract][Full Text] [Related]
58. Endothelial progenitor cells, bronchopulmonary dysplasia and other short-term outcomes of extremely preterm birth. Paviotti G; Fadini GP; Boscaro E; Agostini C; Avogaro A; Chiandetti L; Baraldi E; Filippone M Early Hum Dev; 2011 Jul; 87(7):461-5. PubMed ID: 21511414 [TBL] [Abstract][Full Text] [Related]
59. Airway angiopoietin-2 in ventilated very preterm infants: association with prenatal factors and neonatal outcome. Thomas W; Seidenspinner S; Kramer BW; Wirbelauer J; KawczyĆska-Leda N; Szymankiewicz M; Speer CP Pediatr Pulmonol; 2011 Aug; 46(8):777-84. PubMed ID: 21337734 [TBL] [Abstract][Full Text] [Related]
60. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Reiss I; Landmann E; Heckmann M; Misselwitz B; Gortner L Arch Gynecol Obstet; 2003 Nov; 269(1):40-4. PubMed ID: 12682849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]